Drug Development Consultant and Drug Regulatory Consultant
Description: Drug Development Consultancy and Regualtory Consultancy, we provide information and insights on FDA, EMEA, MHRA regulations and pharmaceutical biotechnology drug development
Keywords: drug development, pharmaceutical funding, biotech funding, biotech development, development planning, Pharmaceutical, pharma, pharmacy, chemist, drug, medicine, NCE, Drug development, planning, development planning, testing, biotechnology, biotech, biopharma, biological, regulatory, regs, guidelines, agency, FDA, USA FDA, US FDA, food and drug administration, fedral drug administration, EMEA, European medicines evaluation agency, MHRA, UK drug agency, medicines and health regulatory authority, ICH, international commission on harmonisation, licensing, commercialisation, royalty, sales, sale, deal, clinical, human study, clinical study, clinical trial, pre-clinical, preclinical, non-clinical, nonclinical, animal study, animal testing, consultant, expert, advice, advisory, consulting, consult, new chemical entity, compound, chemical, active substance, API, active pharmaceutical ingredient, experiment, registration, NDA, New Drug application, CTX, CTA, clinical trial application, IND, investigational new drug, protocol, IB, investigators brochure, ethics committee submission, ethics, ethics submission, regulatory submission, biologic, bio, biotherapy, therapeutic agent, treatment, regulatory agency, drug agency, legal agency, NIH, national institute of health, GCP, good clinical practice, GLP, good laboratory practice, GMP, good manufacturing practice, ICH GCP, Phase 1, Phase1, PhaseI, phase II, Phase One, Phase2, phase 2, phase II, PhaseII, Phase two, phase 3, phase3, PhaseIII, phase III, phase three, Phase4, phase 4, phase IV, phaseIV, phase four, ethical study, efficacy study, clinical study, business consultant, consultancy, mentor, medical device, audit, GMP audit, GCP audit, GLP audit
Tags: damienbove, drug, consultant, development, regulatory, feed, free, strategy, recognised, expertise, rss, consultation, consultants, freestrategyconsultation, ida, featured, fda, consultancy, april, january, september, june, october, november, february, regulations, march, december, pain, comment, pharmaceutical, phase, guidance, chronic, emea, biotechnology, syndromes, new, information, july,
Damienbove.com
|
Content Revalency:
Title: 80.00%
Description: 50.00%
Keywords: 14.88% | Document size: 34,398 bytes
More info: Whois - Trace Route - RBL Check |
|
| DAMIENBOVE.COM - Site Location | |
| Country/Flag | |
| City/Region/Zip Code | , , |
| Organization | 1&1 Internet AG |
| Internet Service Provider | 1&1 Internet AG |
| DAMIENBOVE.COM - Domain Information | |
| Domain | DAMIENBOVE.COM [ Traceroute RBL/DNSBL lookup ] |
| Registrar | 1&1 INTERNET SE 1&1 Internet SE |
| Registrar URL | http://registrar.1and1.info |
| Whois server | whois.1and1.com |
| Created | 15-Mar-2007 |
| Updated | 09-Feb-2017 |
| Expires | 15-Mar-2018 |
| Time Left | 142 days 10 hours 23 minutes |
| Status | clientTransferProhibited https://icann.org/epp#clientTransferProhibited clientTransferProhibited https://www.icann.org/epp#clientTransferProhibited |
| DNS servers | NS-UK.1AND1-DNS.BIZ 217.160.81.3 NS-UK.1AND1-DNS.CO.UK 217.160.80.3 NS-UK.1AND1-DNS.COM 217.160.82.3 NS-UK.1AND1-DNS.ORG 217.160.83.3 |
| DAMIENBOVE.COM - DNS Information | |
| IP Address | 82.165.210.171 ~ Whois - Trace Route - RBL Check |
| Domain Name Servers | ns67.1and1.co.uk 217.160.80.173 ns68.1and1.co.uk 217.160.81.173 |
| Mail Exchange | mx01.1and1.co.uk 217.72.192.67 mx00.1and1.co.uk 212.227.15.41 |
| Site Response Header | |
| Response | HTTP/1.1 200 OK |
| Server | Apache |
| Date | Sun, 10 Apr 2011 17:49:40 GMT |
| Content-Type | text/html; charset=UTF-8 |
| Cookie | PHPSESSID=b2ad83342ffc8b1e276e9e958f22ed52; path=/ |